Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

InflaRx studies IFX-1 for ANCA-associated vasculitis in phase II

Oct. 31, 2018

Adaptive and innate immunity is two-way street

Oct. 31, 2018

FDA approves Afluria Quadrivalent for use in individuals age 6 months and older

Oct. 24, 2018

CureVac begins phase I trial with prophylactic mRNA rabies vaccine CV-7202

Oct. 24, 2018

Japanese researchers present ROR-gammaT antagonists

Oct. 24, 2018

ConsortiaTx signs license for foundational intellectual property related to CTX-944

Oct. 24, 2018

Mitsubishi Tanabe Pharma and Pharma Foods enter strategic research collaboration

Oct. 23, 2018

Lianyungang Ruzhong Pharmaceutical Co. and collaborators describe new IDO/TDO inhibitors

Oct. 17, 2018

FDA clears IND for phase I trial of CK-0801 in treatment-resistant Guillain-Barre syndrome

Oct. 16, 2018

Restorbio reports additional phase IIb data on RTB-101

Oct. 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...